FDA Announces Nationwide Blood Pressure Medication Recall
Inventia Healthcare recalled more than 13,000 bottles of chlorthalidone tablets due to failed dissolution specifications, prompting a Class II classification from the Food and Drug Administration on September 17. The nationwide recall affects specific 25-milligram prescription lots manufactured by the company, following an initial recall initiated by the firm back in June. Understanding the Chlorthalidone … Read more